Vietnam startup Jio Health raises US$20m in Series B round
VIETNAM-BASED healthcare startup Jio Health has completed a US$20 million Series B investment led by Singapore-based investor, Heritas Capital, it said in a press statement on Wednesday (Mar 9).
Other investors included Fuchsia Ventures, Kasikorn Bank Group and existing investor Monk's Hill Ventures.
Founded in 2014, the startup is building an omnichannel healthcare "ecosystem" for consumers. The company provides telemedicine, e-prescription fulfilment, digital medical records and data analytics for clinical decision support. Jio Health offerings also extend to physical locations such as on-demand home care, neighbourhood pharmacies and medical clinics.
Founder and chief executive officer of Jio Health, Raghu Rai said the company currently has 150 multi-specialty care providers on its platform. The average number of patients and services were not disclosed.
Funds from this investment will be used to extend Jio Health's clinical service offering to more consumers and employers, support the launch of additional Smart Clinics in existing and new geographies, expand provider and clinical support teams, and further advance technology platform innovation.
"Our Series B funding will substantially accelerate our growth and scale the reach, impact and affordability of our consumer healthcare ecosystem," said Rai.
Amendment note: Jio Health raised US$20 million in the Series B round, not US$30 million. The article has been amended to reflect this.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Buyer for England striker Harry Kane’s former mansion must pay £3.4 million after abandoning deal
Ohmyhome Ltd sells real estate business for US$1 due to poor business and continued losses
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future